Literature DB >> 11028458

Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.

F H Wezeman1, M A Emanuele, S F Moskal, J Steiner, N Lapaglia.   

Abstract

Alendronate is an aminobisphosphonate that inhibits bone resorption in osteoporotic humans and rats but does not induce osteomalacia. Several bisphosphonates, including alendronate, also have direct positive actions on osteoblasts, bone formation, and mineralization. We studied the effects of alendronate on skeletal development in adolescent male rats during chronic alcohol intake. Four groups of age- and weight-matched male Sprague-Dawley rats (35 days of age) were fed the Lieber-DeCarli diet containing 36% of calories as EtOH (E), the EtOH diet plus 60 mg/kg alendronate (EA) every other day intraperitoneally (ip), an isocaloric diet (I), or the isocaloric diet plus 60 mg/kg alendronate (IA) every other day ip. Body weight, femur length, serum levels of osteocalcin (OC), insulin-like growth factor 1 (IGF-1), testosterone, and luteinizing hormone (LH); femur distal metaphyseal and middiaphyseal bone mineral density (BMD) and tibial metaphyseal gene expression for alpha-1-type I collagen (Col I), OC, and bone alkaline phosphatase (AP); and femur strength by four-point bending to failure were measured after 28 days of feeding and alendronate injections. Serum alcohol levels at death were 156 +/- 13 mg/dl (E) and 203 +/- 40 mg/dl (EA). Alendronate given to alcohol-fed rats increased metaphyseal BMD by more than 3-fold over rats fed alcohol alone. Alendronate given to isocaloric pair-fed rats increased metaphyseal BMD by more than 2.5-fold over rats fed the isocaloric diet alone. Cortical BMD was reduced by alcohol but was increased by alendronate. Alcohol consumption reduced serum IGF-1 levels, and alendronate increased IGF-1 levels in alcohol-fed rats. Serum OC, testosterone, and LH were unaffected by alcohol and alendronate. Quantitative dot blot hybridization using rat complementary DNA (cDNA) probes and normalization against 18S subunit ribosomal RNA (rRNA) levels revealed no changes in tibial metaphyseal gene expression for type I collagen, osteocalcin, or alkaline phosphatase. Alcohol significantly reduced the biomechanical properties of the femurs that were partially compensated by alendronate. Chronic alcohol consumption uncouples formation from ongoing resorption, and resorption is inhibited by alendronate. However, alendronate's positive effects on osteoblast-mediated mineralization during chronic alcohol consumption point to the potential use of bisphosphonates in the treatment of decreased bone formation secondary to alcohol-induced diminished osteoblast function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028458     DOI: 10.1359/jbmr.2000.15.10.2033

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.

Authors:  Ryan Himes; Frederick H Wezeman; John J Callaci
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

2.  Partial Protection by Dietary Antioxidants Against Ethanol-Induced Osteopenia and Changes in Bone Morphology in Female Mice.

Authors:  Alexander W Alund; Kelly E Mercer; Casey F Pulliam; Larry J Suva; Jin-Ran Chen; Thomas M Badger; Martin J J Ronis
Journal:  Alcohol Clin Exp Res       Date:  2016-12-17       Impact factor: 3.455

3.  TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.

Authors:  E J Jang; H Jeong; J O Kang; N J Kim; M S Kim; S H Choi; S E Yoo; J H Hong; M A Bae; E S Hwang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

4.  Binge alcohol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone.

Authors:  John J Callaci; Dainius Juknelis; Avinash Patwardhan; Frederick H Wezeman
Journal:  Alcohol Clin Exp Res       Date:  2006-04       Impact factor: 3.455

5.  The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.

Authors:  John J Callaci; Dainius Juknelis; Avinash Patwardhan; Mark Sartori; Nathan Frost; Frederick H Wezeman
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455

6.  Alcohol and bone.

Authors:  Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2014-01-30

7.  Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.

Authors:  Frederick H Wezeman; Dainius Juknelis; Ryan Himes; John J Callaci
Journal:  Bone       Date:  2007-06-15       Impact factor: 4.398

Review 8.  Cellular and molecular mechanisms of alcohol-induced osteopenia.

Authors:  Zhenhua Luo; Yao Liu; Yitong Liu; Hui Chen; Songtao Shi; Yi Liu
Journal:  Cell Mol Life Sci       Date:  2017-07-03       Impact factor: 9.261

9.  Spine bone mineral density and vertebral body height are altered by alcohol consumption in growing male and female rats.

Authors:  Frederick H Wezeman; Dainius Juknelis; Nathan Frost; John J Callaci
Journal:  Alcohol       Date:  2003 Aug-Oct       Impact factor: 2.405

10.  Impact of Alcohol on Bone Health, Homeostasis and Fracture repair.

Authors:  Jonathan M Eby; Farah Sharieh; John J Callaci
Journal:  Curr Pathobiol Rep       Date:  2020-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.